BackEikon Therapeutics Common Stock Overview

Eikon Therapeutics Common Stock Net Income

Profitability analysis for EIKN.

Quarterly Net Income

-$82.96M

As of Mar 2026

Annual Net Income (TTM)

N/A

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...